ParkinsonFranceV1, PascalFrancis, Corpus, bibRecord, 001B74

Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy

Identifieur interne : 001B74 ( PascalFrancis/Corpus ); précédent : 001B73; suivant : 001B75

Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy

Auteurs : B. Pillon ; B. Dubois ; A. Ploska ; Y. Agid

Source :

Neurology [ 0028-3878 ] ; 1991.

RBID : Pascal:91-0532082

Descripteurs français

Pascal (Inist)
- Trouble cognition, Parkinson maladie, Chorée Huntington, Démence Alzheimer, Ophtalmoplégie supranucléaire, Maladie héréditaire, Maladie dégénérative, Démence, Etude comparative, Indice gravité, Exploration, Psychométrie, Système nerveux pathologie, Homme.

English descriptors

KwdEn :
- Alzheimer disease, Cognitive disorder, Comparative study, Degenerative disease, Dementia, Exploration, Genetic disease, Human, Huntington disease, Nervous system diseases, Parkinson disease, Psychometrics, Severity score, Supranuclear ophthalmoplegia.

Abstract

To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0028-3878`
A02	`01`			`@0 NEURAI`
A03		`1`		`@0 Neurol.`
A05				`@2 41`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy`
A11	`01`	`1`		`@1 PILLON (B.)`
A11	`02`	`1`		`@1 DUBOIS (B.)`
A11	`03`	`1`		`@1 PLOSKA (A.)`
A11	`04`	`1`		`@1 AGID (Y.)`
A14	`01`			`@1 INSERM, U289 @2 Paris 75651 @3 FRA @Z A11011000`
A20				`@1 634-643`
A21				`@1 1991`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 6345 @3 354000014350320050/NUM`
A44				`@0 0000`
A45				`@0 76 ref.`
A47	`01`	`1`		`@0 91-0532082`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Trouble cognition`
C03	`03`	`X`	`FRE`	`@0 Parkinson maladie`
C03	`04`	`X`	`FRE`	`@0 Chorée Huntington`
C03	`05`	`X`	`FRE`	`@0 Démence Alzheimer`
C03	`06`	`X`	`FRE`	`@0 Ophtalmoplégie supranucléaire`
C03	`08`	`X`	`FRE`	`@0 Maladie héréditaire`
C03	`09`	`X`	`FRE`	`@0 Maladie dégénérative`
C03	`10`	`X`	`FRE`	`@0 Démence`
C03	`12`	`X`	`FRE`	`@0 Etude comparative`
C03	`14`	`X`	`FRE`	`@0 Indice gravité`
C03	`16`	`X`	`FRE`	`@0 Exploration`
C03	`17`	`X`	`FRE`	`@0 Psychométrie`
C03	`21`	`X`	`FRE`	`@0 Système nerveux pathologie`
C03	`23`	`X`	`FRE`	`@0 Homme`
C03	`01`	`X`	`ENG`	`@0 Cognitive disorder`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease`
C03	`04`	`X`	`ENG`	`@0 Huntington disease`
C03	`05`	`X`	`ENG`	`@0 Alzheimer disease`
C03	`06`	`X`	`ENG`	`@0 Supranuclear ophthalmoplegia`
C03	`08`	`X`	`ENG`	`@0 Genetic disease`
C03	`09`	`X`	`ENG`	`@0 Degenerative disease`
C03	`10`	`X`	`ENG`	`@0 Dementia`
C03	`12`	`X`	`ENG`	`@0 Comparative study`
C03	`14`	`X`	`ENG`	`@0 Severity score`
C03	`16`	`X`	`ENG`	`@0 Exploration`
C03	`17`	`X`	`ENG`	`@0 Psychometrics`
C03	`21`	`X`	`ENG`	`@0 Nervous system diseases`
C03	`23`	`X`	`ENG`	`@0 Human`
C03	`01`	`X`	`SPA`	`@0 Trastorno cognoscitivo`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad`
C03	`04`	`X`	`SPA`	`@0 Corea Huntington`
C03	`05`	`X`	`SPA`	`@0 Demencia Alzheimer`
C03	`06`	`X`	`SPA`	`@0 Oftalmoplejía supranuclear`
C03	`08`	`X`	`SPA`	`@0 Enfermedad hereditaria`
C03	`09`	`X`	`SPA`	`@0 Enfermedad degenerativa`
C03	`10`	`X`	`SPA`	`@0 Demencia`
C03	`12`	`X`	`SPA`	`@0 Estudio comparativo`
C03	`14`	`X`	`SPA`	`@0 Indicio gravedad`
C03	`16`	`X`	`SPA`	`@0 Exploración`
C03	`17`	`X`	`SPA`	`@0 Psicometría`
C03	`21`	`X`	`SPA`	`@0 Sistema nervioso patología`
C03	`23`	`X`	`SPA`	`@0 Hombre`
C04	`01`	`X`		`@0 PU10!01,14`
N21				`@1 124`

Format Inist (serveur)

NO :	PASCAL 91-0532082 INIST
ET :	Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy
AU :	PILLON (B.); DUBOIS (B.); PLOSKA (A.); AGID (Y.)
AF :	INSERM, U289/Paris 75651/France (A11011000)
DT :	Publication en série; Niveau analytique
SO :	Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 1991; Vol. 41; No. 5; Pp. 634-643; Bibl. 76 ref.
LA :	Anglais
EA :	To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery
CC :	002B17G
FD :	Trouble cognition; Parkinson maladie; Chorée Huntington; Démence Alzheimer; Ophtalmoplégie supranucléaire; Maladie héréditaire; Maladie dégénérative; Démence; Etude comparative; Indice gravité; Exploration; Psychométrie; Système nerveux pathologie; Homme
ED :	Cognitive disorder; Parkinson disease; Huntington disease; Alzheimer disease; Supranuclear ophthalmoplegia; Genetic disease; Degenerative disease; Dementia; Comparative study; Severity score; Exploration; Psychometrics; Nervous system diseases; Human
SD :	Trastorno cognoscitivo; Parkinson enfermedad; Corea Huntington; Demencia Alzheimer; Oftalmoplejía supranuclear; Enfermedad hereditaria; Enfermedad degenerativa; Demencia; Estudio comparativo; Indicio gravedad; Exploración; Psicometría; Sistema nervioso patología; Hombre
LO :	INIST-6345
ID :	91-0532082

Links to Exploration step

Pascal:91-0532082

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy</title>
<author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name>
</author>
<author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name>
</author>
<author><name sortKey="Ploska, A" sort="Ploska, A" uniqKey="Ploska A" first="A." last="Ploska">A. Ploska</name>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">91-0532082</idno>
<date when="1991">1991</date>
<idno type="stanalyst">PASCAL 91-0532082 INIST</idno>
<idno type="RBID">Pascal:91-0532082</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B74</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy</title>
<author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name>
</author>
<author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name>
</author>
<author><name sortKey="Ploska, A" sort="Ploska, A" uniqKey="Ploska A" first="A." last="Ploska">A. Ploska</name>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
</author>
</analytic>
<series><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurol.</title>
<idno type="ISSN">0028-3878</idno>
<imprint><date when="1991">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurol.</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer disease</term>
<term>Cognitive disorder</term>
<term>Comparative study</term>
<term>Degenerative disease</term>
<term>Dementia</term>
<term>Exploration</term>
<term>Genetic disease</term>
<term>Human</term>
<term>Huntington disease</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Psychometrics</term>
<term>Severity score</term>
<term>Supranuclear ophthalmoplegia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Trouble cognition</term>
<term>Parkinson maladie</term>
<term>Chorée Huntington</term>
<term>Démence Alzheimer</term>
<term>Ophtalmoplégie supranucléaire</term>
<term>Maladie héréditaire</term>
<term>Maladie dégénérative</term>
<term>Démence</term>
<term>Etude comparative</term>
<term>Indice gravité</term>
<term>Exploration</term>
<term>Psychométrie</term>
<term>Système nerveux pathologie</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0028-3878</s0>
</fA01>
<fA02 i1="01"><s0>NEURAI</s0>
</fA02>
<fA03 i2="1"><s0>Neurol.</s0>
</fA03>
<fA05><s2>41</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PILLON (B.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DUBOIS (B.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>PLOSKA (A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>AGID (Y.)</s1>
</fA11>
<fA14 i1="01"><s1>INSERM, U289</s1>
<s2>Paris 75651</s2>
<s3>FRA</s3>
<sZ>A11011000</sZ>
</fA14>
<fA20><s1>634-643</s1>
</fA20>
<fA21><s1>1991</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6345</s2>
<s3>354000014350320050/NUM</s3>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>76 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>91-0532082</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Trouble cognition</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chorée Huntington</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Démence Alzheimer</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Ophtalmoplégie supranucléaire</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Maladie héréditaire</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Démence</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Etude comparative</s0>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Indice gravité</s0>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Exploration</s0>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Psychométrie</s0>
</fC03>
<fC03 i1="21" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03>
<fC03 i1="23" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Cognitive disorder</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Huntington disease</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Alzheimer disease</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Supranuclear ophthalmoplegia</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Genetic disease</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Degenerative disease</s0>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Dementia</s0>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Comparative study</s0>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Severity score</s0>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Exploration</s0>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Psychometrics</s0>
</fC03>
<fC03 i1="21" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03>
<fC03 i1="23" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Trastorno cognoscitivo</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Corea Huntington</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Demencia Alzheimer</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Oftalmoplejía supranuclear</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Enfermedad hereditaria</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Demencia</s0>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Estudio comparativo</s0>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Indicio gravedad</s0>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Exploración</s0>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Psicometría</s0>
</fC03>
<fC03 i1="21" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03>
<fC03 i1="23" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC04 i1="01" i2="X"><s0>PU10!01,14</s0>
</fC04>
<fN21><s1>124</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 91-0532082 INIST</NO>
<ET>Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy</ET>
<AU>PILLON (B.); DUBOIS (B.); PLOSKA (A.); AGID (Y.)</AU>
<AF>INSERM, U289/Paris 75651/France (A11011000)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 1991; Vol. 41; No. 5; Pp. 634-643; Bibl. 76 ref.</SO>
<LA>Anglais</LA>
<EA>To investigate differences in severity and specificity of cognitive impairment among various neurodegenerative diseases, we tested groups of patients presenting with senile dementia of the Alzheimer type (SDAT; 44), progressive supranuclear palsy (PSP; 45), Huntington's disease (HD; 35) and Parkinson's disease (PD; 164), with an extensive neuropsychological battery</EA>
<CC>002B17G</CC>
<FD>Trouble cognition; Parkinson maladie; Chorée Huntington; Démence Alzheimer; Ophtalmoplégie supranucléaire; Maladie héréditaire; Maladie dégénérative; Démence; Etude comparative; Indice gravité; Exploration; Psychométrie; Système nerveux pathologie; Homme</FD>
<ED>Cognitive disorder; Parkinson disease; Huntington disease; Alzheimer disease; Supranuclear ophthalmoplegia; Genetic disease; Degenerative disease; Dementia; Comparative study; Severity score; Exploration; Psychometrics; Nervous system diseases; Human</ED>
<SD>Trastorno cognoscitivo; Parkinson enfermedad; Corea Huntington; Demencia Alzheimer; Oftalmoplejía supranuclear; Enfermedad hereditaria; Enfermedad degenerativa; Demencia; Estudio comparativo; Indicio gravedad; Exploración; Psicometría; Sistema nervioso patología; Hombre</SD>
<LO>INIST-6345</LO>
<ID>91-0532082</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B74 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001B74 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:91-0532082
   |texte=   Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy

Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri